Advertisement

Physiopathologie et génétique de la migraine

  • A. DucrosEmail author

Résumé

Avec sa forte prévalence et son pronostic bénin, la migraine résulte probablement d’altérations subtiles mais complexes du fonctionnement cérébral. Cette maladie paroxystique évolue par crises aux caractéristiques éminemment variables d’un patient à l’autre et parfois d’une crise à l’autre [1]. La céphalée en est le symptôme principal mais de multiples autres manifestations peuvent survenir avant, pendant et après la douleur, et celle-ci peut même être absente. Les deux variétés principales de crises sont la migraine sans aura (MSA) et la migraine avec aura (MA) dans laquelle la céphalée est précédée ou accompagnée de troubles neurologiques transitoires visuels, sensitifs, aphasiques et rarement moteurs ou basilaires [2]. Certains patients ont uniquement des MSA, d’autres uniquement des MA, et d’autres ont les deux. Pour certains, MSA et MA sont deux entités séparées qui peuvent coexister par hasard chez le même patient [3, 4]. D’autres considèrent la migraine comme une affection unique ayant un large spectre clinique allant de la MSA pure à une extrémité, jusqu’à la migraine avec aura complexe ou hémiplégique à l’autre extrémité [5].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Charles A (2009) Advances in the basic and clinical science of migraine. Ann Neurol 65(5): 491–8PubMedCrossRefGoogle Scholar
  2. 2.
    IHS, Society. HCCotIH (2004) The international classification of headache disorders. Cephalalgia 24(Suppl 1): 1–160Google Scholar
  3. 3.
    Russell MB, Olesen J (1995) Increased familial risk and evidence of genetic factor in migraine. Bmj 311(7004): 541–4PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Russell MB, Iselius L, Olesen J (1996) Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 16(5): 305–9PubMedCrossRefGoogle Scholar
  5. 5.
    De Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM (2009) Molecular genetics of migraine. Hum Genet 126(1): 115–32PubMedCrossRefGoogle Scholar
  6. 6.
    Tfelt-Hansen PC (2010) History of migraine with aura and cortical spreading depression from 1941 and onwards. Cephalalgia 30(7): 780–92PubMedGoogle Scholar
  7. 7.
    Eikermann-Haerter K, Yuzawa I, Qin T et al. (2011) Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J Neurosci 31(15): 5755–63PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Leo L, Gherardini L, Barone V, De Fusco M, Pietrobon D, Pizzorusso T et al. (2011) Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PLoS Genet 7(6): e1002129PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Eikermann-Haerter K, Baum MJ, Ferrari MD et al. (2009) Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice. Ann Neurol 66(4): 564–8PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Weiller C, May A, Limmroth V et al. (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1(7): 658–60PubMedCrossRefGoogle Scholar
  11. 11.
    Denuelle M, Fabre N, Payoux P et al. (2007) Hypothalamic activation in spontaneous migraine attacks. Headache 47(10): 1418–26PubMedGoogle Scholar
  12. 12.
    Bolay H, Reuter U, Dunn AK et al. (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8(2): 136–42PubMedCrossRefGoogle Scholar
  13. 13.
    Olesen J, Friberg L, Olsen TS et al. (1990) Timing and topography of cerebral blood fow, aura, and headache during migraine attacks. Ann Neurol 28(6): 791–8PubMedCrossRefGoogle Scholar
  14. 14.
    Woods R P, Iacoboni M, Mazziotta JC (1994) Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 331(25): 1689–92PubMedCrossRefGoogle Scholar
  15. 15.
    Denuelle M, Fabre N, Payoux P et al. (2008) Posterior cerebral hypoperfusion in migraine without aura. Cephalalgia 28(8): 856–62PubMedCrossRefGoogle Scholar
  16. 16.
    Goadsby PJ, Sprenger T (2010) Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 9(3): 285–98PubMedCrossRefGoogle Scholar
  17. 17.
    Schoenen J (2006) Neurophysiological features of the migrainous brain. Neurol Sci 27(Suppl 2): S77–81PubMedCrossRefGoogle Scholar
  18. 18.
    Stankewitz A, May A (2007) Cortical excitability and migraine. Cephalalgia 27(12): 1454–6PubMedCrossRefGoogle Scholar
  19. 19.
    Boulloche N, Denuelle M, Payoux P et al. (2010) Photophobia in migraine: an interictal PET study of cortical hyperexcitability and its modulation by pain. J Neurol Neurosurg Psychiatry 81(9): 978–84PubMedCrossRefGoogle Scholar
  20. 20.
    Denuelle M, Boulloche N, Payoux P et al. (2011) A PET study of photophobia during spontaneous migraine attacks. Neurology 76(3): 213–8PubMedCrossRefGoogle Scholar
  21. 21.
    Russell MB, Ducros A (2011) Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 10(5): 457–70PubMedCrossRefGoogle Scholar
  22. 22.
    Ophoff RA, Terwindt GM, Vergouwe MN et al. (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2 + channel gene CACNL1A4. Cell 87(3): 543–52PubMedCrossRefGoogle Scholar
  23. 23.
    Dichgans M, Freilinger T, Eckstein G et al. (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366(9483): 371–7PubMedCrossRefGoogle Scholar
  24. 24.
    De Fusco M, Marconi R, Silvestri L et al. (2003) Haploinsufficiency of ATP1A2 encoding the Na +/K + pump α2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33(2): 192–6PubMedCrossRefGoogle Scholar
  25. 25.
    Thomsen LL, Eriksen MK, Romer SF et al. (2002) An epidemiological survey of hemiplegic migraine. Cephalalgia 22(5): 361–75CrossRefGoogle Scholar
  26. 26.
    Thomsen LL, Ostergaard E, Olesen J, Russell MB (2003) Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology 60(4): 595–601PubMedCrossRefGoogle Scholar
  27. 27.
    Ducros A, Denier C, Joutel A et al. (2001) The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 345(1): 17–24PubMedCrossRefGoogle Scholar
  28. 28.
    Jurkat-Rott K, Freilinger T, Dreier JP et al. (2004) Variability of familial hemiplegic migraine with novel A1A2 Na (+)/K (+)-ATPase variants. Neurology 62(10): 1857–61PubMedCrossRefGoogle Scholar
  29. 29.
    Thomsen LL, Eriksen MK, Roemer SF (2002) A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 125 (Pt 6): 1379–91PubMedCrossRefGoogle Scholar
  30. 30.
    Kors EE, Terwindt GM, Vermeulen FL et al. (2001) Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol 49(6): 753–60PubMedCrossRefGoogle Scholar
  31. 31.
    Kors EE, Haan J, Giffin NJ et al. (2003) Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch Neurol 60(5): 684–8PubMedCrossRefGoogle Scholar
  32. 32.
    Thomsen LL, Kirchmann M, Bjornsson A et al. (2007) The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain 130 (Pt 2): 346–56PubMedCrossRefGoogle Scholar
  33. 33.
    Riant F, Ducros A, Ploton C (2010) De novo mutations in ATP1A2 and CACNA1A are frequent in early onset sporadic hemiplegic migraine. Neurology 75(11): 967–72PubMedCrossRefGoogle Scholar
  34. 34.
    Cloarec R, Bruneau N, Rudolf G et al. (2012) PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. NeurologyGoogle Scholar
  35. 35.
    Dale RC, Gardiner A, Antony J, Houlden H (2012) Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. Dev Med Child Neurol 54(10): 958–60PubMedCrossRefGoogle Scholar
  36. 36.
    Gardiner AR, Bhatia KP, Stamelou M et al. (2012) PRRT2 gene mutations: From paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. NeurologyGoogle Scholar
  37. 37.
    Marini C, Conti V, Mei D et al. (2012) PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology 79(21): 2109–14PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Riant F, Roze E, Barbance C et al. (2012) PRRT2 mutations cause hemiplegic migraine. NeurologyGoogle Scholar
  39. 39.
    Chen WJ, Lin Y, Xiong ZQ et al. (2011) Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 43(12): 1252–5PubMedCrossRefGoogle Scholar
  40. 40.
    Wang JL, Cao L, Li XH et al. (2011) Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 134 (Pt 12): 3493–501PubMedCrossRefGoogle Scholar
  41. 41.
    Schubert J, Paravidino R, Becker F et al. (2012) PRRT2 Mutations are the major cause of benign familial infantile seizures. Hum Mutat 33(10): 1439–43PubMedCrossRefGoogle Scholar
  42. 42.
    Heron SE, Grinton BE, Kivity S et al. (2012) PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet 90(1): 152–60PubMedCentralPubMedCrossRefGoogle Scholar
  43. 43.
    De Vries B, Freilinger T, Vanmolkot KR et al. (2007) Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. Neurology 69(23): 2170–6PubMedCrossRefGoogle Scholar
  44. 44.
    Thomsen LL, Oestergaard E, Bjornsson A et al. (2008) Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients. Cephalalgia 28(9): 914–21PubMedCrossRefGoogle Scholar
  45. 45.
    Moskowitz MA, Bolay H, Dalkara T (2004) Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol 55(2): 276–80PubMedCrossRefGoogle Scholar
  46. 46.
    Tottene A, Pivotto F, Fellin T et al. (2005) Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J Biol Chem 280(18): 17678–86PubMedCrossRefGoogle Scholar
  47. 47.
    Tottene A, Conti R, Fabbro A et al. (2009) Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca (v) 2.1 knockin migraine mice. Neuron 61(5): 762–73PubMedCrossRefGoogle Scholar
  48. 48.
    Van den Maagdenberg AM, Pietrobon D, Pizzorusso T et al. (2004) à Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41(5): 701–10PubMedCrossRefGoogle Scholar
  49. 49.
    Eikermann-Haerter K, Dilekoz E, Kudo C et al. (2009) Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 119(1): 99–109PubMedCentralPubMedGoogle Scholar
  50. 50.
    Van den Maagdenberg AM, Pizzorusso T, Kaja S et al. (2010) High cortical spreading depression susceptibility and migraine-associated symptoms in Ca (v) 2.1 S218L mice. Ann Neurol 67(1): 85–98PubMedCrossRefGoogle Scholar
  51. 51.
    Segall L, Mezzetti A, Scanzano R et al. (2005) Alterations in the α2 isoform of Na, K-ATPase associated with familial hemiplegic migraine type 2. Proc Natl Acad Sci 102(31): 11106–11PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Nyholt DR, LaForge KS, Kallela M et al. (2008) à high-density association screen of 155 ion transport genes for involvement with common migraine. Hum Mol Genet 17(21): 3318–31PubMedCentralPubMedCrossRefGoogle Scholar
  53. 53.
    Lafreniere RG, Cader MZ, Poulin JF et al. (2010) A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med 16(10): 1157–60PubMedCrossRefGoogle Scholar
  54. 54.
    Anttila V, Stefansson H, Kallela M et al. (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22. 1. Nat Genet 42(10): 869–73PubMedCentralPubMedCrossRefGoogle Scholar
  55. 55.
    Chasman DI, Schurks M, Anttila V et al. (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 43(7): 695–8PubMedCentralPubMedCrossRefGoogle Scholar
  56. 56.
    Freilinger T, Anttila V, de Vries B et al. (2012) Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 44(7): 777–82PubMedCentralPubMedCrossRefGoogle Scholar
  57. 57.
    Bousser MG, Welch KM (2005) Relation between migraine and stroke. Lancet Neurol 4(9): 533–42PubMedCrossRefGoogle Scholar
  58. 58.
    Dalkara T, Nozari A, Moskowitz MA (2010) Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol 9(3): 309–17PubMedCentralPubMedCrossRefGoogle Scholar
  59. 59.
    Nozari A, Dilekoz E, Sukhotinsky I et al. (2010) Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 67(2): 221–9PubMedCentralPubMedCrossRefGoogle Scholar
  60. 60.
    Eikermann-Haerter K, Yuzawa I, Dilekoz E et al. (2011) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol 69(2): 413–8PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Paris 2014

Authors and Affiliations

  1. 1.Département de NeurologieHôpital Gui de ChauliacMontpellier Cedex 5France

Personalised recommendations